EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics

Qiurui He iD, Weibing Li, Jiaxuan Xiang, Jingjing Mu, Yuying Miao, Zhirong Su, Jianchun Qin iD, Feng Wang

Molecules · 2026

DOI: 10.3390/molecules31203661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Qiurui He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Yuncheng University, Yuncheng 044000, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Computational Biology, Network Pharmacology, Breast Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Shanxi Province, Shanxi Provincial Education Department, Fundamental Research Program of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chaetomugilin Q has demonstrated anti-tumor effects in preclinical models. However, the potential mechanisms of chaetomugilin Q in treating breast cancer remain unclear. This study used network pharmacology and molecular docking prediction to explore these mechanisms and prioritize candidate targets of chaetomugilin Q in breast cancer. PharmMapper, SuperPred, and GalaxySagittarius-AF were utilized to obtain targets associated with chaetomugilin Q, while GeneCards, CTD, DrugBank, OMIM, and TTD were used to collect breast cancer-related targets. A total of 299 overlapping candidate targets were obtained using Venny 2.1.0. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using the DAVID tool. These candidate targets were input into the STRING database and Cytoscape 3.10.1 software to construct a protein–protein interaction (PPI) network and prioritize candidate core targets. Molecular docking prediction was performed using the CB-Dock2 server. The candidate core targets were further analyzed using GEPIA, HPA, cBioPortal, Kaplan–Meier Plotter, and TIMER. After GO and KEGG enrichment analyses, 1174 relevant terms and 169 signaling pathways were identified, respectively. PIK3R1, HSP90AA1, SRC, AKT1, STAT3, PIK3CD, PIK3CB, EGFR, GRB2, and ESR1 were prioritized as candidate core targets. Molecular docking results showed that the predicted docking scores of chaetomugilin Q to the candidate core targets were lower than −5 kcal/mol. Bioinformatics analyses based on independent public databases indicated that these candidate core targets exhibited differential expression at the mRNA and protein levels and were associated with patient prognosis, mutation status, and immune cell infiltration, providing clinical and biological context. This study provides a computational prediction of the potential mechanisms of chaetomugilin Q against breast cancer and a theoretical basis for subsequent experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationComputational BiologyNetwork PharmacologyBreast NeoplasmsAntineoplastic AgentsHumansFemaleProtein Interaction MapsGene Ontology

Stichwörter der Autor:innen

breast cancerchaetomugilin Qmolecular dockingmolecular mechanismsnetwork pharmacology

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Life Science, Yuncheng University, Yuncheng 044000, China.
  • College of Plant Science, Jilin University, Changchun 130062, China.
  • Featured Fruit Quality Control and Application Laboratory, Department of Food and Health, Yuncheng University, Yuncheng 044000, China.

ORCID-Profile: Qiurui He, Jianchun Qin

Förderung

  • Science and Technology Department of Shanxi Province
  • Shanxi Provincial Education Department
  • Fundamental Research Program of Shanxi Province
  • Innovation Laboratory Platform in Shanxi Province of China

Zitieren

APA

He, Q., Li, W., Xiang, J., Mu, J., Miao, Y., Su, Z., Qin, J., & Wang, F. (2026). Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics. Molecules. https://doi.org/10.3390/molecules31203661

Vancouver

He Q, Li W, Xiang J, Mu J, Miao Y, Su Z, et al. Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics. Molecules. 2026. doi:10.3390/molecules31203661

BibTeX
@article{He2026,
  author = {He, Qiurui and Li, Weibing and Xiang, Jiaxuan and Mu, Jingjing and Miao, Yuying and Su, Zhirong and Qin, Jianchun and Wang, Feng},
  title = {Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31203661}
}
Kostenlos starten →